Closed · RFA-HS-20-003 · CFDA 93.226 · Discretionary

Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19 (R01)

Federal grant opportunity posted by Agency for Health Care Research and Quality, cataloged on Grants.gov.

Varies
Award range
Closed
Status
June 15, 2020
Close date
-
Expected awards

The verdict

Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19 (R01) is a closed discretionary listing from Agency for Health Care Research and Quality that offered Varies by applicant. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 197 other opportunities from Agency for Health Care Research and Quality.

Varies
award range
Closed
application status
93.226
CFDA program
197
other opportunities from Agency for Health Care Research and Quality

Archived opportunity record

Novel, High-Impact Studies Evaluating Health… is closed (last close June 15, 2020). The parent program page for CFDA 93.226 is the reliable place to catch re-announcements. Agency for Health Care Research and Quality still indexes 197 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed June 15, 2020

Posted May 14 Closes Jun 15

Instrument

Grant

Description

This Funding Opportunity Announcement (FOA) invites R01 grant applications for funding to support novel, high-impact studies evaluating the responsiveness of healthcare delivery systems, healthcare professionals, and the overall U.S. healthcare system to the COVID-19 pandemic. AHRQ is interested in funding critical research focused on evaluating topics such as effects on quality, safety, and value of health system response to COVID-19; the role of primary care practices and professionals during the COVID-19 epidemic; understanding how the response to COVID-19 affected socially vulnerable populations and people with multiple chronic conditions; and digital healthcare including innovations and challenges encountered in the rapid expansion of telehealth response to COVID-19. AHRQ encourages multi-method, rapid-cycle research with the ability to: produce and disseminate initial findings (e.g. observations, lessons learned, or findings) within 6 months after award and then regularly throughout the remainder of the award period.

Market-open applicant set · includes for-profit door

The eligibility set for Novel, High-Impact Studies Evaluating Health… includes a for-profit door among 11 printed types (State governments; Special district governments; Public / state-controlled institutions of higher education; Federally recognized tribal governments; +7 more). Competitive traffic can include commercial applicants alongside other listed classes. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity code maps to Health (HL). Inside Agency for Health Care Research and Quality's indexed book this exact eligibility-code string is unique to this listing.

Code 00
State governments
Code 04
Special district governments
Code 06
Public / state-controlled institutions of higher education
Code 07
Federally recognized tribal governments
Code 08
Public / Indian housing authorities
Code 11
Native American tribal organizations (other than Federally recognized tribal governments)
Code 12
Nonprofits with 501(c)(3) status (other than IHEs)
Code 13
Nonprofits without 501(c)(3) status (other than IHEs)
Code 20
Private institutions of higher education
Code 23
Small businesses
Code 25
Others (see official listing text)

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

Kathryn Marron, Ph.D. Receipt and Referral Officer Agency for Healthcare Research and Quality, HHS Office: (301) 427-1554 Email: Kathryn.Marron@ahrq.hhs.gov Kathryn.Marron@ahrq.hhs.gov

What to do next

Novel, High-Impact Studies Evaluating Health… is closed; use the parent program and agency catalog for the next funding cycle.

  • Parent CFDA 93.226 may publish future NOFOs under the same assistance listing. Open program
  • Health Care Facilities Cooperation indexes 8 Grants.gov listings in this extract. Program profile
  • Agency for Health Care Research and Quality lists 197 other indexed opportunities on PlainGrants. Agency catalog

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants